Becton, Dickinson and Co. news

   Watch this stock
Showing stories 1 - 10 of about 29   

Articles published

BDX 144.33 -0.02 (-0.01%)
price chart
Recent cases show that utilitarian functionality is a serious � and common ...
In other words, courts may consider whether alternative product designs are available, and whether the cost or time involved in using an alternative design makes it impractical.
Asuragen Grants Armored RNA� Technology License to BD
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that it has granted BD (Becton, Dickinson and Company), a global medical technology company, non-exclusive worldwide rights to incorporate Armored RNA� technology into its in vitro ...
Related articles »  
JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose ...
FRANKLIN LAKES, N.J. and NEW YORK, June 7, 2012 /PRNewswire-USNewswire/ -- JDRF and BD (Becton, Dickinson and Company) (NYSE: BDX) today announced an extension of their existing collaboration focused on Type 1 diabetes (T1D) to accelerate ...
JDRF, BD Expand Diabetes Collaboration to Develop Continuous Glucose ...  Genetic Engineering News
Related articles »  
DaVita to Cut Energy Use 15% Per Treatment by 2015
Dialysis provider DaVita Inc. plans to cut its energy consumption 15 percent per treatment by 2015 as part of a larger environmental initiative.
Get on the right side of the sharps practice law
At an event organised by Nursing Times and sponsored by medical devices manufacturer Becton Dickinson, he told the group of nursing directors and deputy chief nurses that he felt proud this law was coming onto the statute books.
Eric Schoenstein: High Growth Stock Picks With Quality Management
Becton, Dickinson and Company (BDX, Earnings, Analysts, Financials): Develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
Ezose Sciences Announces Appointment of Chief Operating Officer
He has served in R&D capacities at Phytera, Inc., Centocor, Inc., and Becton Dickinson and Co., and as Adjunct Associate Professor of Microbiology at the University of Pennsylvania.
Related articles »  
TEXT-S&P affirms Hologic 'BB' rating
Hologic will continue facing challenges in improving its products against such substantial competitors as Johnson & Johnson, General Electric Co., and Becton Dickinson & Co. Even so, we do not expect competitive threats to develop rapidly, given its ...
Related articles »  
IPO Releases List of Top 300 Patent Holders for 2011
Life sciences companies and organizations that failed to make the IPO top 300 in 2011 after making it in 2010 included Boehringer Ingelheim International GmbH (#260 on the IPO top 300 for 2010), Becton, Dickinson and Co. (263), Columbia University (272 ...
Related articles »  
Research and Markets: Disposable Syringe Markets
This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications.